Insmed Incorporated: H.C. Wainwright assumes coverage with buy rating; target price $220
INSM•H.C. Wainwright assumed coverage of Insmed Incorporated with a buy rating and a $220 target price.
Related News
AdvanSix Q3 sales rise on higher pricing
ASIX•
VICI Properties Inc: Mizuho cuts target price to $26 from $27
VICI•
Mizuho cuts Mosaic target price to $20 from $22
MOS•
Cinemark Holdings target price raised by Wells Fargo to $42 from $34
CNK•
Advanced Micro Devices: Stifel raises target price to $725 from $700
AMD•